|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
7 months to Dec 31, 2023
|
|
|---|---|---|---|
| Other Income (Expenses): | |||
| Loss from equity method investment in Operating Partnership | |||
| Net loss | |||
| Comprehensive loss from Operating Partnership | |||
| Comprehensive loss from Operating Partnership | |||
| Comprehensive loss | |||
| Net loss per common share, basic | |||
| Net loss per common share, diluted | |||
| Weighted average number of common shares outstanding, basic | |||
| Weighted average number of common shares outstanding, diluted |
Loading...
